Cargando…

The efficacy of the treat-repair-treat strategy for severe pulmonary arterial hypertension associated with congenital heart disease: a meta-analysis

BACKGROUND: This meta-analysis was conducted to evaluate the efficacy of the treat-repair-treat (TRT) strategy in the treatment of severe pulmonary arterial hypertension with congenital heart disease (PAH-CHD). METHODS: PubMed, EMBASE, Cochrane and Web of Science online databases were searched by tw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhiyuan, Li, Xiaobing, Li, Mengxuan, Peng, Jun, Zhang, Huijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662905/ https://www.ncbi.nlm.nih.gov/pubmed/37986143 http://dx.doi.org/10.1186/s12872-023-03606-z

Ejemplares similares

Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension
por: Takaya, Yoichi, et al.
Publicado: (2022)

Pushing the envelope: a treat and repair strategy for patients with advanced pulmonary hypertension associated with congenital heart disease
por: Kameny, Rebecca Johnson, et al.
Publicado: (2017)

Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension
por: Xu, Zhuoyuan, et al.
Publicado: (2021)

Comparative Efficacy and Safety of Prostacyclin Analogs for Pulmonary Arterial Hypertension: A Network Meta-Analysis
por: Zhang, Huijun, et al.
Publicado: (2016)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Riociguat for pulmonary arterial hypertension associated with congenital heart disease
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease
por: Arshad, Hassaan B., et al.
Publicado: (2021)

MicroRNA-204 as an Indicator of Severity of Pulmonary Hypertension in Children with Congenital Heart Disease Complicated with Pulmonary Hypertension
por: Li, Xu, et al.
Publicado: (2019)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)

Treat-and-repair strategy is a feasible therapeutic choice in adult patients with severe pulmonary arterial hypertension associated with a ventricular septal defect: case series
por: Akagi, Satoshi, et al.
Publicado: (2018)

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017)

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2018)

Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease
por: Condliffe, R., et al.
Publicado: (2018)

The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
por: van Dissel, Alexandra C., et al.
Publicado: (2017)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
por: Lopes, Antonio, et al.
Publicado: (2014)

Pulmonary artery ablation to treat pulmonary arterial hypertension: a case report
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2015)

Apoptosis-based therapy to treat pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2016)

The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario
por: Vaid, Haris M., et al.
Publicado: (2016)

Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease
por: Xi, Shi-Bing, et al.
Publicado: (2019)

Effect of Dexmedetomidine on Pulmonary Artery Pressure in Children with Congenital Heart Disease and Pulmonary Hypertension
por: Kanchi, Muralidhar, et al.
Publicado: (2020)

Palliative Senning in the Treatment of Congenital Heart Disease with Severe Pulmonary Hypertension
por: da Penha, Juliano Gomes, et al.
Publicado: (2015)

Advanced Pulmonary Hypertension Due to Congenital Double-shunt Successfully Treated with Surgical Repair and Up-front Combination Therapy
por: Suto, Makiko, et al.
Publicado: (2019)

Pulmonary hypertension in congenital heart disease
por: Pascall, Emma, et al.
Publicado: (2018)

The expression of survivin in irreversible pulmonary arterial hypertension rats and its value in evaluating the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
por: Li, Gang, et al.
Publicado: (2019)

Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
por: Huang, Li, et al.
Publicado: (2018)

Atrial flow regulator for severe drug resistant pulmonary arterial hypertension after congenital heart defect correction
por: Dąbrowska-Kugacka, Alicja, et al.
Publicado: (2019)

Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease
por: Schuuring, M. J., et al.
Publicado: (2011)

Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases
por: Zhang, Xi, et al.
Publicado: (2016)

Pulmonary valve reconstruction for acquired pulmonary regurgitation in patients with treated congenital heart disease
por: Jussli-Melchers, Jill, et al.
Publicado: (2023)

Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
por: Abughazaleh, Shaadi, et al.
Publicado: (2020)

Critical decision of operability in congenital heart disease patient with severe pulmonary hypertension
por: Joshi, Raja, et al.
Publicado: (2016)

Treating Severe Hypertension
por: Swales, J. D.
Publicado: (1984)

The relationship between endothelial progenitor cells and pulmonary arterial hypertension in children with congenital heart disease
por: Sun, Hong-Xiao, et al.
Publicado: (2019)

Potential biomarkers and targets in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study
por: Huang, Li, et al.
Publicado: (2018)

Piezo1, a novel therapeutic target to treat pulmonary arterial hypertension
por: Yang, Qifeng, et al.
Publicado: (2023)

Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease
por: Zhu, Na, et al.
Publicado: (2018)

Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
por: Awad, Abdulhalim, et al.
Publicado: (2022)

Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
por: Yaylalı, Yalın Tolga, et al.
Publicado: (2023)

Pulmonary vasodilators can lead to various complications in pulmonary “arterial” hypertension associated with congenital heart disease
por: Chida-Nagai, Ayako, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7dcj7bjfvnu6vg4ruecinurh62